FY26 Results: Losses Widen Sharply, Revenue Declines
Transgene Biotek Ltd · 526139 · BSE ·
• **Net Loss:** Widened by 144.5% to ₹(165.29) Lakhs for FY26, compared to a loss of ₹(67.61) Lakhs in FY25. • **Revenue:** Revenue from operations fell 19% year-over-year to ₹21.12 Lakhs. • **Earnings Per Share (EPS):** Stood at ₹(0.22) for the year, down from ₹(0.09) in the pre…